These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 11421881)

  • 1. Arrest of chronic acid suppressant drug use after successful Helicobacter pylori eradication in patients with peptic ulcer disease: a six-month follow-up study.
    Hurenkamp GJ; Grundmeijer HG; Van Der Ende A; Tytgat GN; Assendelft WJ; Van Der Hulst RW
    Aliment Pharmacol Ther; 2001 Jul; 15(7):1047-54. PubMed ID: 11421881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The effect of Helicobacter pylori eradication on chronic use of acid-suppressant medication by patients in general practice; a randomised, double-blind study].
    Hurenkamp GJ; Grundmeijer HG; van der Ende A; Tytgat GN; Assendelft WJ; van der Hulst RW
    Ned Tijdschr Geneeskd; 2004 Nov; 148(48):2390-6. PubMed ID: 15615275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Long-term course of reflux symptoms following Helicobacter pylori eradication].
    Peitz U; Raps S; Plein K; Leodolter A; Hotz Dagger J; Malfertheiner P
    Dtsch Med Wochenschr; 2004 Mar; 129(13):671-5. PubMed ID: 15026962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Symptomatic benefit 1-3 years after H. pylori eradication in ulcer patients: impact of gastroesophageal reflux disease.
    McColl KE; Dickson A; El-Nujumi A; El-Omar E; Kelman A
    Am J Gastroenterol; 2000 Jan; 95(1):101-5. PubMed ID: 10638566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does Helicobacter pylori eradication reduce the long-term requirements for acid suppressants in patients with a history of peptic ulcer disease in general practice? Results from a four-year longitudinal study.
    Khan Z; Nair P; O'Shea C; Spiers N; Playford RJ; Wicks AC
    Scand J Gastroenterol; 2002 Feb; 37(2):144-7. PubMed ID: 11843048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Six-year follow-up after successful triple therapy for Helicobacter pylori infection in patients with peptic ulcer disease.
    van der Wouden EJ; Thijs JC; van Zwet AA; Kleibeuker JH
    Eur J Gastroenterol Hepatol; 2001 Oct; 13(10):1235-9. PubMed ID: 11711782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patients with dyspepsia benefit from eradication of Helicobacter pylori if other organic causes for dyspepsia were carefully ruled out.
    Bojarski C; Epple HJ; Kirstein FW; Fromm M; Bisson S; Riecken EO; Schulzke JD
    Z Gastroenterol; 2000 Mar; 38(3):211-9. PubMed ID: 10768243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maintenance treatment is not necessary after Helicobacter pylori eradication and healing of bleeding peptic ulcer: a 5-year prospective, randomized, controlled study.
    Liu CC; Lee CL; Chan CC; Tu TC; Liao CC; Wu CH; Chen TK
    Arch Intern Med; 2003 Sep; 163(17):2020-4. PubMed ID: 14504114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Helicobacter pylori eradication or of ranitidine plus metoclopramide on Helicobacter pylori-positive functional dyspepsia. A randomized, controlled follow-up study.
    Alizadeh-Naeeni M; Saberi-Firoozi M; Pourkhajeh A; Taheri H; Malekzadeh R; Derakhshan MH; Massarrat S;
    Digestion; 2002; 66(2):92-8. PubMed ID: 12428068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A 1 year follow-up study of the consequences of Helicobacter pylori eradication in duodenal ulcer patients: unchanged frequency of erosive oesophagitis and decreased prevalence of non-erosive gastro-oesophageal reflux disease.
    Kupcinskas L; Jonaitis L; Kiudelis G
    Eur J Gastroenterol Hepatol; 2004 Apr; 16(4):369-74. PubMed ID: 15028968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomised controlled trial of Helicobacter pylori eradication in patients on non-steroidal anti-inflammatory drugs: HELP NSAIDs study. Helicobacter Eradication for Lesion Prevention.
    Hawkey CJ; Tulassay Z; Szczepanski L; van Rensburg CJ; Filipowicz-Sosnowska A; Lanas A; Wason CM; Peacock RA; Gillon KR
    Lancet; 1998 Sep; 352(9133):1016-21. PubMed ID: 9759744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eradication of Helicobacter pylori has no effect on gastric acidity in duodenal ulcer patients--evaluation of 24-h pH monitoring.
    Rácz I; Szabó A; Csöndes M; Pécsi G; Goda M
    J Physiol Paris; 2001; 95(1-6):469-75. PubMed ID: 11595477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of long-term outcome of functional dyspepsia and duodenal ulcer after successful Helicobacter pylori eradication--a 7-year follow-up study.
    Maconi G; Sainaghi M; Molteni M; Bosani M; Gallus S; Ricci G; Alvisi V; Porro GB
    Eur J Gastroenterol Hepatol; 2009 Apr; 21(4):387-93. PubMed ID: 19182682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Helicobacter pylori eradication and antisecretory maintenance therapy on peptic ulcer recurrence in cirrhotic patients: a prospective, cohort 2-year follow-up study.
    Tzathas C; Triantafyllou K; Mallas E; Triantafyllou G; Ladas SD
    J Clin Gastroenterol; 2008 Jul; 42(6):744-9. PubMed ID: 18277886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of a Helicobacter pylori treatment strategy on health care expenditures in patients with peptic ulcer disease and dyspepsia.
    Kearney DJ; Liu CF; Crump C; Brousal A
    Am J Gastroenterol; 2003 Sep; 98(9):1952-62. PubMed ID: 14499771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of screening for Helicobacter pylori in patients with duodenal ulceration in the primary health care setting.
    Rosengren H; Polson RJ
    Br J Gen Pract; 1996 Mar; 46(404):177-9. PubMed ID: 8731626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eradication of Helicobacter pylori prevents ulcer development in patients with ulcer-like functional dyspepsia.
    Hsu PI; Lai KH; Tseng HH; Lo GH; Lo CC; Lin CK; Cheng JS; Chan HH; Ku MK; Peng NJ; Chien EJ; Chen W; Hsu PN
    Aliment Pharmacol Ther; 2001 Feb; 15(2):195-201. PubMed ID: 11148437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of symptomatic response as predictor of Helicobacter pylori status following eradication therapy in patients with ulcer.
    McColl KE; el-Nujumi A; Murray LS; el-Omar EM; Dickson A; Kelman AW; Hilditch TE
    Gut; 1998 May; 42(5):618-22. PubMed ID: 9659153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study of outcome after targeted intervention for peptic ulcer resistant to acid suppression therapy.
    Lanas A; Remacha B; Sáinz R; Hirschowitz BI
    Am J Gastroenterol; 2000 Feb; 95(2):513-9. PubMed ID: 10685760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the dyspeptic patient: a cost-utility study.
    Ebell MH; Warbasse L; Brenner C
    J Fam Pract; 1997 Jun; 44(6):545-55. PubMed ID: 9191627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.